In 2030, there is a boom in precision medicine, where diseases – from cancer to dementia – are defined and targeted more specifically with a focus on their molecular makeup.
The advent of genetic technologies has been reducing the time and cost attached to diagnosing rare genetic diseases.
The rise of personalised medicine, which is mainly based on genetic testing, needs adequate regulation so privacy rights aren't breached. That's only one of several issues that must be considered.
A new study has identified that pancreatic cancer is not one, but four types of cancer, and opened the door to possible new treatments.
Personalised medicine is based on the idea that by understanding the specific molecular code of a person’s disease, and particularly its genetic makeup, we can more accurately tailor treatment.